Home › Funds › PFM Health Sciences, LP › DFTX

PFM Health Sciences, LP position in DFTX

DEFINIUM THERAPEUTICS INC · Health Care

PFM Health Sciences, LP reported holding 249,020 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$11.7M, representing 1.03% of its reported portfolio and ranking #36 among its reported holdings. PFM Health Sciences, LP has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)249.02K sh
Reported value held$11.71M
Portfolio Weight1.03%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's DFTX position evolved

PFM Health Sciences, LP first disclosed a stake in DFTX in Q1 2026 at 205,317 shares (US$3.9M). The position peaked in Q2 2026 at 249,020 shares, worth US$11.7M. Across 2 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 249,020 shares valued at US$11.7M — an increase of 43,703 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 205.32K $3.88M New
Q2 2026 249.02K $11.71M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DFTX and 13F data

DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 189 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DFTX

All DFTX fund holders →

FAQ

How long has PFM Health Sciences, LP held DFTX?

PFM Health Sciences, LP has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is PFM Health Sciences, LP's current position in DFTX?

As of Q2 2026, PFM Health Sciences, LP holds 249.02K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $11.71M, representing 1.03% of its reported portfolio and ranking #36.

Has PFM Health Sciences, LP been buying or selling DFTX?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP increased its position in DFTX. The position peaked in Q2 2026 at 249.02K shares.

Which other funds hold DFTX?

Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 189 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.